Lesaffre publicizes the completion of its take-over of NattoPharma, a Norwegian nutraceutical firm specializing in analysis and advertising and marketing of vitamin K2. With this acquisition, Gnosis by Lesaffre, the enterprise unit of Lesaffre devoted to human care, is strengthening its presence within the world human diet and well being market and confirms its dedication to speed up its analysis and improvement actions.
This announcement completes the pleasant public supply launched in February to accumulate all excellent shares of NattoPharma, an organization listed on Euronext Expand Oslo. Given that Lesaffre now holds greater than 90% of the share capital of NattoPharma, a delisting and obligatory acquisition of the remaining shares can be carried out sooner or later.
Lesaffre pursues its investments and improvement in human diet and well being sector
As a world participant within the discipline of fermentation and micro-organisms, Lesaffre has been increasing its capabilities in human diet and well being for greater than 15 years. With the acquisition of NattoPharma, an organization headquartered in Norway and specializing in vitamin K2, Lesaffre confirms its dedication to changing into a key participant on this double-digit-growth market.
Through its enterprise unit Gnosis by Lesaffre, Lesaffre is already a longtime provider of Vitamin K2, an ingredient utilized in dietary dietary supplements, with advantages in bone well being and cardiovascular well being. Joining forces with NattoPharma will assist Gnosis by Lesaffre increase the attention about and entry to the advantages of Vitamin K2 to assist the well being capital of customers.
‘This acquisition is completely according to our technique of improvement in human diet and well being. We are very glad to welcome the NattoPharma staff inside our group. Lesaffre and NattoPharma share a standard objective of answering the wants for meals, well being and naturalness whereas offering protected and reliable substances to their purchasers and finish clients’, says Antoine Baule, CEO of Lesaffre.
Gnosis by Lesaffre needs to strengthen its presence and providing
Gnosis by Lesaffre has been creating merchandise for human diet and well being for greater than 15 years and presently employs over 400 individuals in its varied websites (France, Italy, Switzerland, USA, China and Singapore). This operation will allow the enterprise unit to strengthen its presence within the world human diet and well being market and to additional develop the entry to pure vitamin K2.
‘By becoming a member of our forces and mixing our expertises, we are going to speed up our investments in medical trials to analysis and show vitamin K2 results for the advantage of customers, and thus additional improve science-based differentiation levers for our clients,‘ provides Marc Philouze, Managing Director of Gnosis By Lesaffre.
NattoPharma is a nutraceutical firm based in 2004 and headquartered in Oslo. Since its inception, the corporate has performed a number one position in constructing the medical science to substantiate the well being advantages of vitamin K2 with greater than 20 revealed medical trials. It sells K2 below its model MenaQ7® and by way of a world gross sales group with salespeople positioned in Europe, USA and Asia.
‘I’m happy with the entrepreneurial journey achieved by the NattoPharma staff to construct the Vitamin K2 market and supporting science over the previous decade. Lesaffre is acknowledged as a worldwide key participant within the fermentation trade, leveraging innovation and industrial platforms to supply fermentation merchandise; this, paired with NattoPharma’s experience on the assorted types of Vitamin K2, makes us assured that we collectively will speed up analysis and additional discover K2 advantages because the true world chief in Vitamin K2 with a full vary of merchandise assembly all buyer wants,’ says Kjetil Ramsoy, CEO of NattoPharma.
Rothschild acted as monetary advisor to Lesaffre. Thommessen AS acted because the Norwegian authorized advisor, and Linklaters because the French authorized advisor to Lesaffre. ABG Sundal Collier ASA acted as monetary advisor and CLP DA as Norwegian authorized advisor to NattoPharma.
